1. Electromagnetic fields oxidative stress and neurodegeneration;Consales;Int. Cell Biology,2012
2. COST Action BM1309: European network for innovative uses of EMFs in biomedical applications (EMF-MED). Available at: http://cost-emf-med.eu/ (accessed 28.07.15).
3. COST Action EP4Bio2Med: European network for development of electroporation-based technologies and treatments. Available at: http://www.electroporation.net/ (accessed 28.07.15).
4. Directive 2013/35/EU of the European Parliament and of the Council. Official Journal of the European Union L179/1.
5. EFHRAN Report. Risk analysis of human exposure to electromagnetic fields (revised), 2012. Project funded by Executive Agency for Health and Consumers Framework of the Programme of Community Action in the Field of Health 2008–2013.